Charles Schwab’s Crescent Biopharma CBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $67.1K | Hold |
|
|||||
|
2023
Q4 | $52.8K | Hold |
|
|||||
|
2023
Q3 | $33.5K | Hold |
|
|||||
|
2023
Q2 | $38.9K | Hold |
|
|||||
|
2023
Q1 | $28.2K | Hold |
|
|||||
|
2022
Q4 | $67.8K | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $37K | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $51K | Hold |
|
|||||
|
2021
Q3 | $77K | Buy |
|
|||||
|
2021
Q2 | $27K | Sell |
|
|||||
|
2021
Q1 | $264K | Hold |
|
|||||
|
2020
Q4 | $330K | Hold |
|
|||||
|
2020
Q3 | $270K | Sell |
|
|||||
|
2020
Q2 | $332K | Buy |
|
|||||
|
2020
Q1 | $187K | Hold |
|
|||||
|
2019
Q4 | $433K | Hold |
|
|||||
|
2019
Q3 | $353K | Hold |
|
|||||
|
2019
Q2 | $975K | Buy |
|
|||||
|
2019
Q1 | $980K | Buy |
|
|||||
|
2018
Q4 | $724K | Hold |
|
|||||
|
2018
Q3 | $1.1M | Buy |
|
|||||
|
2018
Q2 | $1.19M | Buy |
|
|||||
|
2017
Q2 | – | Sell |
|
|||||
|
2017
Q1 | $107K | Hold |
|
|||||
|
2016
Q4 | $120K | Hold |
|
|||||
|
2016
Q3 | $141K | Hold |
|
|||||
|
2016
Q2 | $143K | Buy |
|